Aptivus 250 mg/1 (Tipranavir CAPSULE, LIQUID FILLED) 250 mg/1

Aptivus 250 mg/1 is a liquid-filled capsule containing tipranavir, used for managing certain medical conditions. This medication is designed for oral administration and is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.

Strength

250 mg/1

Pack Size

120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0597-0003-02)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aptivus 250 mg/1 is primarily used in combination with other medications to treat specific health conditions. Tipranavir, the active ingredient, is often utilized in regimens aimed at managing viral infections. The medication is prescribed by healthcare professionals to address these conditions, and it is important to follow their guidance for optimal results.

Side Effects

Common effects of Aptivus 250 mg/1 may include gastrointestinal discomfort, nausea, and dizziness. Some individuals might experience changes in taste or fatigue. These effects can vary among users, and it is essential to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Aptivus 250 mg/1 should be handled with care, stored as directed, and kept out of reach of children. It is crucial to inform healthcare providers about any allergies or existing medical conditions before starting this medication. Adherence to prescribed dosages and regular follow-ups can help manage potential risks.

Avoid Interactions

Aptivus 250 mg/1 may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. Alcohol and other substances that affect liver function should be avoided unless approved by a healthcare provider. Always disclose all current medications to your healthcare professional to prevent adverse interactions.

Frequently Asked Questions

Aptivus 250 mg/1 is used in combination with other medications to manage certain viral infections.

Aptivus 250 mg/1 is taken orally, typically with food, as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, nausea, dizziness, and changes in taste.

Aptivus 250 mg/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with any other treatments.

Aptivus 250 mg/1 should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.